CVS Health lowers Q3 earnings outlook, appoints David Joyner as new CEO.

CVS Health Corporation's stock fell in pre-market trading after it lowered its third-quarter earnings outlook and announced the appointment of David Joyner as the new president and CEO, succeeding Karen Lynch. The adjusted earnings per share forecast (EPS) of $1.05-$1.10 significantly undercuts Wall Street's $1.69 estimate. The company previously reported strong earnings in Q2, but revenue was below expectations.